Scott Ward spent nearly three decades working for med-tech giant Medtronic, holding several senior leadership positions. Since 2013, he’s been a managing director with Bloomington-based SightLine Partners, a venture capital and private equity firm investing in med-tech and health care companies. In 2015 he was tapped as interim CEO for New Brighton-based Cardiovascular Systems Inc.; the job became permanent in 2016 after longtime CEO David Martin died of cancer. Ward has been leading a turnaround of CSI, getting the company into better financial shape by growing revenue and cutting losses. For fiscal 2017, revenue was up 15 percent, to $204.9 million.